Insulin resistance and blood flow after heart attack treatment
Part of Heart & circulation clinical trials.
This study looks at how insulin resistance affects blood flow after a common heart attack procedure (stenting) in people with type 2 diabetes. It may help doctors understand why some patients have poor blood flow after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have type 2 diabetes
- You are having a heart procedure called PCI (stenting) for a heart attack
- You do not have a history of heart attack or heart failure
- You are not in cardiogenic shock
- You have not had prior heart stenting or bypass surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation and blood cell counts are related in people with diabetes who have a heart attack and are treated with a stent. It may help doctors understand how to better care for these patients.
This study looks at whether giving medication before the heart procedure can reduce tiny blood-vessel blockages (and “no-flow” areas) after a certain type of heart attack. It may help improve heart blood flow right after treatment in people who meet specific procedure and timing criteria.
This study compares short-term outcomes in people with type 2 diabetes who have a heart attack and receive a stent, depending on whether they were taking insulin or oral diabetes medications before the event. It aims to see if one treatment leads to better recovery.
This study compares two ways to restore blood flow to the heart—stent placement (PCI) versus bypass surgery (CABG)—in people with diabetes and significant multi-vessel coronary artery disease. It looks at outcomes using both standard heart tests and additional imaging/functional measurements to guide the best revascularization strategy.
This study looks at how insulin resistance affects recovery after a heart attack or unstable angina in people without diabetes. It may help understand why some patients have worse outcomes.
This study measures how your body handles sugar and related hormones in people after a new STEMI heart attack, and compares them with people who do not have diabetes or have prediabetes. The goal is to better understand metabolic changes after the event, which could help future care.
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.